Pfizer (PFE) reported its Q2 2026 financial results before the market open on August 4, 2026. The company posted an earnings per share (EPS) of 0.77 USD, beating the analyst estimate of 0.68 USD by 12.9%. Revenue for the quarter reached 15034 million USD. Following the release, the stock price rose by 1.52%.
Generated automatically from our data — as of August 15, 2026
Key figures at a glance
Estimate (EPS): 0.68 USD
Reported (EPS): 0.77 USD
Price reaction: +1.5%
Frequently asked questions
Did Pfizer beat or miss earnings-per-share expectations?
Pfizer beat the analyst estimate of 0.68 USD earnings per share (Q2 2026) by 12.9%, reporting 0.77 USD.
How did Pfizer stock react to the earnings report?
Pfizer stock rose 1.5% on the trading day following the release.
What was Pfizer's revenue in Q2 2026?
Pfizer reported revenue of 15,034M USD in Q2 2026.